SYNT vs. VCT, ELM, ESNT, SCPA, TET, ZTF, IOF, ITX, WCH, and DCTA
Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Itaconix (ITX), Wilmcote Holdings plc (WCH.L) (WCH), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.
In the previous week, Synthomer had 2 more articles in the media than Victrex. MarketBeat recorded 3 mentions for Synthomer and 1 mentions for Victrex. Victrex's average media sentiment score of 0.44 beat Synthomer's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.
Victrex has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500.
Victrex presently has a consensus target price of GBX 1,746.67, suggesting a potential upside of 35.61%. Synthomer has a consensus target price of GBX 234.25, suggesting a potential downside of 19.22%. Given Synthomer's stronger consensus rating and higher probable upside, research analysts plainly believe Victrex is more favorable than Synthomer.
Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 4.7%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 8.6%. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -2,083.3% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.
Synthomer received 217 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.50% of users gave Synthomer an outperform vote while only 63.77% of users gave Victrex an outperform vote.
Victrex has a net margin of 10.81% compared to Victrex's net margin of -3.40%. Synthomer's return on equity of 6.36% beat Victrex's return on equity.
Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.
96.4% of Victrex shares are held by institutional investors. Comparatively, 43.3% of Synthomer shares are held by institutional investors. 1.6% of Victrex shares are held by company insiders. Comparatively, 28.1% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Victrex beats Synthomer on 10 of the 19 factors compared between the two stocks.
Get Synthomer News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Synthomer Competitors List
Related Companies and Tools
